Moreover, it has been reported that in type 2 diabetic patients with adequate glycaemic control by metformin monotherapy, several markers of cardiovascular risk are improved by addition of liraglutide treatment, suggesting that metformin and liraglutide may have additive or even synergistic effects on vasculature 14
Currently, there are 3 GLP-1 agonists that are FDA-approved for the treatment of obesity: Saxenda (Liraglutide)- a once-daily subcutaneous injection given in the back of the arm, the thigh, or the abdomen
The catch is that human efficacy data is essentially absent, and long-term safety in people is unknown
A gut-first plan focuses on appetite signals, meal satisfaction, and steady energy
When does insurance cover injectables
How Pillo Helps With Any Oral GLP-1 Every oral GLP-1 shares one weakness: it is a daily pill, and daily pills are easy to skip